2024
Immunosuppressive strategies in face and hand transplantation: a comprehensive systematic review of current therapy regimens and outcomes
Huelsboemer L, Boroumand S, Kochen A, Dony A, Moscarelli J, Hauc S, Stögner V, Formica R, Pomahac B, Kauke-Navarro M. Immunosuppressive strategies in face and hand transplantation: a comprehensive systematic review of current therapy regimens and outcomes. Frontiers In Transplantation 2024, 3: 1366243. PMID: 38993787, PMCID: PMC11235358, DOI: 10.3389/frtra.2024.1366243.Peer-Reviewed Original ResearchCMV infectionImmunosuppressive regimensImmunosuppressive strategiesTransplant recipientsIncidence of rejection episodesClinical CMV infectionTriple maintenance therapyIncidence of rejectionEpisodes of rejectionIndividualized immunosuppressive regimensEffective immunosuppressive therapySystematic reviewFace transplant patientsHand transplant recipientsHand transplantationFacial graftImmunosuppressive therapyMaintenance therapyRejection episodesFacial mucosaGraft lossGraft rejectionTherapy regimensTransplant patientsRenal failure
2023
Update on long-term mental health outcomes in eight face transplant recipients from a single center
Huelsboemer L, Stögner V, Hosseini H, Hauc S, Boroumand S, Parikh N, Blood A, Mookerjee V, Kauke-Navarro M, Nizzi M, Pomahac B. Update on long-term mental health outcomes in eight face transplant recipients from a single center. The International Journal Of Psychiatry In Medicine 2023, 59: 583-594. PMID: 38152028, DOI: 10.1177/00912174231225764.Peer-Reviewed Original ResearchFace transplant recipientsSelf-reported qualityLong-term psychosocial outcomesMental healthMental health dynamicsLong-term mental healthOngoing psychological supportBetter mental healthBrief COPEPsychological dimensionsPsychological benefitsPsychosocial outcomesLong-term journeyPsychological supportInstrumental supportMixed-method approachDepression scoresFacial disfigurementHealth DynamicsFace transplantationTransplant recipientsOlder ageScoresSupportLast followLow-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study
Murakami N, Borges T, Win T, Abarzua P, Tasigiorgos S, Kollar B, Barrera V, Ho Sui S, Teague J, Bueno E, Clark R, Lian C, Murphy G, Pomahac B, Riella L. Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study. American Journal Of Transplantation 2023, 23: 549-558. PMID: 36740193, PMCID: PMC10318113, DOI: 10.1016/j.ajt.2023.01.016.Peer-Reviewed Original ResearchConceptsLow-dose IL-2 therapyIL-2 therapySkin allograftsFace transplant recipientsTransplant recipientsIL-2Immune regulationLow-dose interleukin-2 (IL-2) therapyHigher acute rejection ratesLow-dose IL-2Face transplantationAcute rejection ratesCytotoxicity-associated genesDose interleukin-2Greater suppressive functionInterleukin-2 therapyAutoimmune hemolytic anemiaRegulatory T cellsNarrow therapeutic windowLife-changing procedureImmunological monitoringTim-3Peripheral bloodImmune modulationHemolytic anemia
2022
In the face of change: Which coping strategies predict better psychosocial outcomes in face transplant recipients?
Nizzi M, Pomahac B. In the face of change: Which coping strategies predict better psychosocial outcomes in face transplant recipients? Frontiers In Psychology 2022, 13: 995222. PMID: 36467137, PMCID: PMC9712221, DOI: 10.3389/fpsyg.2022.995222.Peer-Reviewed Original ResearchBetter mental healthPsychosocial outcomesMental healthLong-term psychosocial outcomesPre-transplant assessmentPost-transplant phasePost-transplant dataTerm psychosocial outcomesQuality of lifePoor mental healthMental health trajectoriesBetter psychosocial outcomesFace transplant recipientsTransplant recipientsTransplant candidatesMeasures of depressionPatients' qualityCoping strategiesPatientsPsychosocial functioningHealth trajectoriesMonthsOptimal outcomesPromising targetOutcomesT cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation
Borges T, Abarzua P, Gassen R, Kollar B, Lima-Filho M, Aoyama B, Gluhova D, Clark R, Islam S, Pomahac B, Murphy G, Lian C, Talbot S, Riella L. T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation. Cell Reports Medicine 2022, 3: 100559. PMID: 35492875, PMCID: PMC9040185, DOI: 10.1016/j.xcrm.2022.100559.Peer-Reviewed Original ResearchConceptsLimb transplantationTransplant recipientsSkin antigen-presenting cellsSolid organ transplant recipientsAccelerated graft rejectionOrgan transplant recipientsSkin transplantation modelAntigen-presenting cellsLife-changing procedureImmunosuppressive approachesTh17 cellsGraft rejectionGreater immunogenicityCell infiltrationSkin biopsiesTransplantation modelSkin xenograftsChemokine CCL18Immune moleculesTransplantationCCL18RecipientsMolecular characterizationChemokinesCCR8 receptor
2019
Novel immunological and clinical insights in vascularized composite allotransplantation
Kollar B, Pomahac B, Riella L. Novel immunological and clinical insights in vascularized composite allotransplantation. Current Opinion In Organ Transplantation 2019, 24: 42-48. PMID: 30531538, DOI: 10.1097/mot.0000000000000592.Peer-Reviewed Original ResearchConceptsAcute rejectionT cellsComposite allotransplantationField of VCANovel immunosuppressive approachAntibody-mediated rejectionCurrent histological classificationNovel noninvasive biomarkersQuality of lifeType of rejectionIntensity of treatmentFace transplant recipientsChronic rejectionImmunosuppressive regimensVCA patientsVCA recipientsAllograft injuryCostimulation blockadeImmunosuppressive approachesImmunosuppressive therapyTransplant recipientsImmune monitoringUpper extremityHistological classificationVCA outcomes
2018
Increased levels of circulating MMP3 correlate with severe rejection in face transplantation
Kollar B, Shubin A, Borges T, Tasigiorgos S, Win T, Lian C, Dillon S, Gu X, Wyrobnik I, Murphy G, Pomahac B, Libermann T, Riella L. Increased levels of circulating MMP3 correlate with severe rejection in face transplantation. Scientific Reports 2018, 8: 14915. PMID: 30297859, PMCID: PMC6175842, DOI: 10.1038/s41598-018-33272-7.Peer-Reviewed Original ResearchConceptsSevere rejectionFace transplantationLarge independent patient cohortsAcute rejection episodesAnti-rejection treatmentFirst postoperative yearLongitudinal serum samplesNon-invasive candidate biomarkersViable treatment optionSOMAscan proteomics platformIndependent patient cohortsFace transplant recipientsRejection episodesPostoperative yearTransplant recipientsDevastating injuriesMMP3 levelsTransplant rejectionHistological gradePatient cohortTreatment optionsSurrogate markerMMP3 proteinCandidate biomarkersTransplantationTrismus in Face Transplantation Following Ballistic Trauma
Krezdorn N, Alhefzi M, Perry B, Aycart M, Tasigiorgos S, Bueno E, Green J, Pribaz J, Pomahac B, Caterson E. Trismus in Face Transplantation Following Ballistic Trauma. Journal Of Craniofacial Surgery 2018, 29: 843-847. PMID: 29381613, DOI: 10.1097/scs.0000000000004271.Peer-Reviewed Original ResearchConceptsFace transplant recipientsTemporomandibular jointFace transplantationTransplant recipientsFunctional outcomeBallistic traumaMouth openingImpaired mouth openingOral food intakeImmediate postoperative periodBallistic injuriesRange of motionPartial face transplantationCovert injuriesIntraoperative releasePersistent trismusTotal condylectomyYear posttransplantPostoperative periodPostoperative planningPostoperative treatmentPrimary injuryIntraoperative evaluationSevere scarringMedical records486 Molecular analysis differentiates inflammatory dermatoses from skin rejection in face transplant recipients
Win T, Dyring-Andersen B, Teague J, Riella L, Pomahac B, Clark R. 486 Molecular analysis differentiates inflammatory dermatoses from skin rejection in face transplant recipients. Journal Of Investigative Dermatology 2018, 138: s82. DOI: 10.1016/j.jid.2018.03.493.Peer-Reviewed Original Research
2017
Outcomes of Solid Organ Transplants After Simultaneous Solid Organ and Vascularized Composite Allograft Procurements
Aycart M, Alhefzi M, Sharma G, Krezdorn N, Bueno E, Talbot S, Carty M, Tullius S, Pomahac B. Outcomes of Solid Organ Transplants After Simultaneous Solid Organ and Vascularized Composite Allograft Procurements. Transplantation 2017, 101: 1381-1386. PMID: 27140518, PMCID: PMC6347371, DOI: 10.1097/tp.0000000000001262.Peer-Reviewed Original ResearchMeSH KeywordsAdultComposite Tissue AllograftsFacial TransplantationFemaleGraft SurvivalHumansMaleMiddle AgedOperative TimeOrgan TransplantationPostoperative ComplicationsRegistriesRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTissue and Organ HarvestingTissue DonorsTreatment OutcomeUnited StatesYoung AdultConceptsGraft survival ratesSolid organsSurvival rateLiver recipientsTransplant recipientsAllograft procurementSolid organ allograftsSolid organ transplantsBrain-dead donorsLong-term outcomesShort-term resultsHeart recipientsIntraoperative parametersDonor surgeryOperative durationOrgan allograftsPostoperative outcomesScientific RegistryTransplantation outcomesPopulation of subjectsCase reportOperative characteristicsUnknown causeNationwide analysisOrgan transplants
2016
2530: Unilateral facial artery is sufficient for vascularized composite allotransplantation of the lower two-thirds of the face - Case report on a face transplant recipient at the Brigham and Women's Hospital
Fischer S, Lee T, Krezdorn N, Alhefzi M, Aycart M, Kiwanuka H, Win T, Bueno E, Tullius S, Pomahac B. 2530: Unilateral facial artery is sufficient for vascularized composite allotransplantation of the lower two-thirds of the face - Case report on a face transplant recipient at the Brigham and Women's Hospital. Vascularized Composite Allotransplantation 2016, 3: 44-44. DOI: 10.1080/23723505.2016.1234256.Peer-Reviewed Original ResearchCodominant Role of Interferon‐γ– and Interleukin‐17–Producing T Cells During Rejection in Full Facial Transplant Recipients
Borges T, O'Malley J, Wo L, Murakami N, Smith B, Azzi J, Tripathi S, Lane J, Bueno E, Clark R, Tullius S, Chandraker A, Lian C, Murphy G, Strom T, Pomahac B, Najafian N, Riella L. Codominant Role of Interferon‐γ– and Interleukin‐17–Producing T Cells During Rejection in Full Facial Transplant Recipients. American Journal Of Transplantation 2016, 16: 2158-2171. PMID: 26749226, PMCID: PMC4979599, DOI: 10.1111/ajt.13705.Peer-Reviewed Original ResearchConceptsDe novo donor-specific antibody developmentDe novo donor-specific antibodiesInterleukin-17-producing T cellsT helper 2 cell phenotypeFacial transplantationDonor-specific antibody developmentNovo donor-specific antibodiesChemotactic protein-1 levelsPeripheral blood mononuclear cellsAcute cellular rejectionAnti-HLA antibodiesDonor-specific antibodiesFollicular helper cellsImmune cell subsetsProtein-1 levelsBlood mononuclear cellsMedium-term outcomesSkin biopsy specimensFull facial transplantationCellular rejection processLife-changing procedureCellular rejectionCodominant roleDonor alloreactivityTransplant recipients
2015
Transformation of Face Transplants: Volumetric and Morphologic Graft Changes Resemble Aging After Facial Allotransplantation
Kueckelhaus M, Turk M, Kumamaru K, Wo L, Bueno E, Lian C, Alhefzi M, Aycart M, Fischer S, De Girolami U, Murphy G, Rybicki F, Pomahac B. Transformation of Face Transplants: Volumetric and Morphologic Graft Changes Resemble Aging After Facial Allotransplantation. American Journal Of Transplantation 2015, 16: 968-978. PMID: 26639618, DOI: 10.1111/ajt.13544.Peer-Reviewed Original ResearchConceptsLong-term outcomesFacial allograftFacial allotransplantationSuperior long-term outcomesShort-term resultsRisk-benefit assessmentSoft tissue volumeSignificant volume lossTransplant recipientsVolume lossDiagnostic evaluationDonor selectionMuscle biopsyHistological evaluationComputed tomographyBone atrophyAllograftsFuture clinical routineNormal anatomyRecipient tissuesAllotransplantationClinical routineMorphometric changesSoft tissueMuscle fibersNoninvasive Monitoring of Immune Rejection in Face Transplant Recipients
Kueckelhaus M, Imanzadeh A, Fischer S, Kumamaru K, Alhefzi M, Bueno E, Wake N, Gerhard-Herman M, Rybicki F, Pomahac B. Noninvasive Monitoring of Immune Rejection in Face Transplant Recipients. Plastic & Reconstructive Surgery 2015, 136: 1082-1089. PMID: 26505709, DOI: 10.1097/prs.0000000000001703.Peer-Reviewed Original ResearchConceptsFace transplant recipientsTransplant recipientsChronic rejectionCLINICAL QUESTION/LEVELAllograft biopsy specimensTotal vessel diameterSolid organ allograftsAllograft lossOrgan allograftsPostsurgical monitoringFlap arteryControl subjectsBiopsy specimensIntimal thicknessClinical signsRadial arteryThicker intimaUltrasound biomicroscopyFacial arteryMedia thicknessHistologic analysisImmune rejectionArteryRecipientsInterobserver correlationA Single Center's Experience with Donation of Facial Allografts for Transplantation
Huang A, Bueno E, Pomahac B. A Single Center's Experience with Donation of Facial Allografts for Transplantation. Vascularized Composite Allotransplantation 2015, 2: 80-87. DOI: 10.1080/23723505.2016.1189992.Peer-Reviewed Original ResearchEpstein-Barr virusIschemia timeImmunologic compatibilityPost-transplant immunosuppressionSingle-center experienceHeart-beating donorsFace transplant recipientsDonor serologyFacial restorationTransplant recipientsHemodynamic stabilityCenter experienceNational Donor RegistryABO compatibilityNegative crossmatchWomen's HospitalDonor procurementHLA typingDonor typeAesthetic outcomeDonor characteristicsInfectious diseasesDonor registryFacial allograftFace transplantation
2014
Acute rejection in vascularized composite allotransplantation
Fischer S, Lian C, Kueckelhaus M, Strom T, Edelman E, Clark R, Murphy G, Chandraker A, Riella L, Tullius S, Pomahac B. Acute rejection in vascularized composite allotransplantation. Current Opinion In Organ Transplantation 2014, 19: 531-544. PMID: 25333831, DOI: 10.1097/mot.0000000000000140.Peer-Reviewed Original ResearchConceptsAcute rejection episodesAcute rejectionRejection episodesComposite allotransplantationDepth histological analysisHigh-dose steroidsLong-term safetyField of transplantationBetter diagnostic toolsFace transplant recipientsMaintenance immunosuppressionSteroid withdrawalTransplant recipientsCommon complicationImmunologic eventsAppropriate therapyPatient numbersTimely institutionRestorative surgeryDose reductionEarly diagnosisMost episodesNovel biomarkersHigh immunogenicityPatient care
2013
Current Principles of Facial Allotransplantation
Pomahac B, Bueno E, Sisk G, Pribaz J. Current Principles of Facial Allotransplantation. Plastic & Reconstructive Surgery 2013, 131: 1069-1076. PMID: 23629089, PMCID: PMC4374342, DOI: 10.1097/prs.0b013e3182865cd3.Peer-Reviewed Original ResearchConceptsTransplant recipientsSurgical principlesFace transplant recipientsFacial allotransplantationFull screening procedureReturn of motorFace transplant candidatesFundamental surgical principlesTransplant candidatesTransplantation teamWomen's HospitalSevere casesSensory functionPatientsUnique caseAllotransplantationClinical volumeFacial disfigurementRecipientsHospitalScreening procedureFacial restorationCurrent principlesBrigham
2012
Craniofacial Principles in Face Transplantation
Caterson E, Diaz-Siso J, Shetye P, Junker J, Bueno E, Soga S, Rybicki F, Pomahac B. Craniofacial Principles in Face Transplantation. Journal Of Craniofacial Surgery 2012, 23: 1234-1238. PMID: 22948648, DOI: 10.1097/scs.0b013e318252d406.Peer-Reviewed Original ResearchConceptsSkull baseFace transplantationFace transplantFace transplant recipientsSella-nasion planeSoft tissue elementsTransplant recipientsAirway functionDonor allograftsAnatomical restorationUpper airwayCraniofacial principlesPostoperative analysisNormal anatomyTransplantationFrankfort horizontal planeSoft tissueHard tissue componentsFunctional effectsCephalometric parametersOrthognathic planningTissue elementsTransplantNormative dataTissue components
2008
Facial Transplantation and Immunosuppressed Patients: A New Frontier in Reconstructive Surgery
Pomahac B, Aflaki P, Chandraker A, Pribaz J. Facial Transplantation and Immunosuppressed Patients: A New Frontier in Reconstructive Surgery. Transplantation 2008, 85: 1693-1697. PMID: 18580458, DOI: 10.1097/tp.0b013e318176b29e.Peer-Reviewed Original ResearchConceptsPartial face transplantationOrgan transplant recipientsFace transplantationTransplant recipientsLife-long immunosuppressionPatient selection criteriaRisk of malignancyComposite tissue transplantationFacial transplantationAlternative reconstructive methodImmunosuppressive regimenImmunosuppressive therapyAdditional immunosuppressionSurgical resectionImmunosuppressed patientsOrgan recipientsPatient populationWomen's HospitalReconstructive surgeryTransplantationIRB approvalSkin cancerReconstructive methodsControversial procedureTissue transplantation